IL13RA2 and neoplasm: Indeed, we demonstrate that pre-treatment of tumor cell lines in vitro with TSA enhanced their sensitivity to IL-13-PE and made IL-13Rα2-negative cell lines extremely sensitive to IL-13-PE.